0.6927
price up icon1.66%   0.0113
 
loading

Pds Biotechnology Corp (PDSB) 最新ニュース

pulisher
Jul 27, 2026

PDS Biotechnology Corp (PDSB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

PDS Biotechnology Corp (PDSB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

PDS Biotechnology Corp (PDSB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

PDSB|PDS Biotechnology Corp|Price:0.699|Chg%:+0.017 - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

PDS Biotechnology Corp (PDSB) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

PDS Biotechnology Corp (PDSB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PDS Biotechnology Corp (PDSB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PDSB|PDS Biotechnology Corp|Price:0.720|Chg%:+0.039 - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

PDSB|PDS Biotechnology Corp|Price:0.681|Chg%:-0.019 - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

PDS Biotechnology Corp. Revenue Breakdown – FWB:EU6 - TradingView

Jul 24, 2026
pulisher
Jul 24, 2026

PDS Biotechnology Corp (PDSB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 22, 2026

PDS Biotechnology Corp SEC Filing (Jul 22, 2026) - Stock Titan

Jul 22, 2026
pulisher
Jul 21, 2026

Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight - GlobeNewswire Inc.

Jul 21, 2026
pulisher
Jul 10, 2026

Form S-3 PDS Biotechnology Corp For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026
pulisher
Jul 10, 2026

PDS Biotechnology (NASDAQ: PDSB) registers 13.3M shares tied to note and warrant deal - Stock Titan

Jul 10, 2026
pulisher
Jun 28, 2026

PDSB | PDS Biotechnology Corporation Common Executive Compensation - Quiver Quantitative

Jun 28, 2026
pulisher
Jun 28, 2026

PDS Biotechnology (PDSB) Hovers Near Support Amid Modest DeclineVolume Breadth - dars.gov.et

Jun 28, 2026
pulisher
Jun 26, 2026

PDS Biotechnology Corp (PDSB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 26, 2026
pulisher
Jun 26, 2026

PDS Biotechnology (NASDAQ: PDSB) details 2026 proxy votes and pay - Stock Titan

Jun 26, 2026
pulisher
Jun 26, 2026

PDS Biotechnology Corp. Actuals & Estimates (NASDAQ:PDSB) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

PDS Biotechnology Corp. Actuals & Estimates (DUS:EU6) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

PDSB Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

PDS Biotech’s Double Squeeze: Nasdaq Clock Ticking as Equity Dilution Looms - AD HOC NEWS

Jun 24, 2026
pulisher
Jun 22, 2026

PDS Biotechnology Corp (PDSB) Institutional Confidence - TradingKey

Jun 22, 2026
pulisher
Jun 17, 2026

PDS Biotechnology Corp (PDSB) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 15, 2026

PDS Biotechnology Closes Financing and Retires Convertible Debentures - TipRanks

Jun 15, 2026
pulisher
Jun 15, 2026

PDS Biotechnology (NASDAQ: PDSB) launches $50M ATM program tied to YA II financing - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

[PRE 14A] PDS Biotechnology Corp Preliminary Proxy Statement - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

PDS Biotechnology (NASDAQ: PDSB) adds $6M note and $50M at-the-market stock program - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

PDS Biotechnology schedules 2026 annual meeting for Aug. 10; stockholder proposal deadline set - TradingView

Jun 15, 2026
pulisher
Jun 15, 2026

PDS Biotechnology (PDSB) schedules 2026 annual meeting and sets June 25 proposal cutoff - Stock Titan

Jun 15, 2026
pulisher
Jun 15, 2026

PDS Biotechnology establishes up to $50M stock offering program - scanx.trade

Jun 15, 2026
pulisher
Jun 13, 2026

PDSB Q1 2026 Earnings: EPS Beat Fails to Lift Shares as Pipeline Progress AwaitedROA Comparison - dars.gov.et

Jun 13, 2026
pulisher
Jun 12, 2026

Here's Why PDS Biotechnology (PDSB) Could be Great Choice for a Bottom Fisher - MSN

Jun 12, 2026
pulisher
Jun 07, 2026

PDS Biotechnology Corporation - MLQ.ai

Jun 07, 2026
pulisher
Jun 03, 2026

PDS Biotechnology Stock Gets Nasdaq Extension as Traders Eye PDSB - Bez Kabli

Jun 03, 2026
pulisher
Jun 02, 2026

PDS Biotechnology (NASDAQ: PDSB) back in compliance with Nasdaq $1.00 bid rule - Stock Titan

Jun 02, 2026
pulisher
May 29, 2026

PDSB Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Pipeline ProgressGuidance Upgrade Report - dars.gov.et

May 29, 2026
pulisher
May 28, 2026

PDS Biotechnology (PDSB) Slides 3.6% as Stock Tests Key Support Near $1.02Breakaway Gap - The Legal Advocate

May 28, 2026
pulisher
May 28, 2026

PDSB Q1 2026 Earnings: Narrower Loss Drives Positive EPS Surprise Amid Pre-Revenue PhaseHealthcare Earnings Report - dars.gov.et

May 28, 2026
pulisher
May 27, 2026

PDSBPDS Biotechnology Corp Stock Price and Quote - Finviz

May 27, 2026
pulisher
May 27, 2026

PDSB Q4 2025 Earnings Call Transcript - Yahoo Finance

May 27, 2026
pulisher
May 27, 2026

PDS Biotechnology Q1 2026 Earnings: EPS Beat on Narrower Loss, Clinical Progress in FocusReturn On Capital - Newser

May 27, 2026
pulisher
May 27, 2026

PDS Biotechnology (PDSB) Edges Higher by 1.82% as Biotech Speculative Interest PersistsIron Condor Alert - dars.gov.et

May 27, 2026
pulisher
May 25, 2026

PDS Biotechnology Q1 2026 Earnings: Narrowed Loss Per Share and Clinical Progress Drive Positive Market ResponseGrowth Acceleration Report - thelegaladvocate.com

May 25, 2026
pulisher
May 24, 2026

PDS Biotechnology Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock Up 3.45%Earnings Growth Forecast - Newser

May 24, 2026
pulisher
May 23, 2026

PDS Biotechnology Q1 2026 Earnings: EPS Beat Highlights Progress Despite Pre-Revenue StatusEarnings Forecast Report - newsline.com

May 23, 2026
pulisher
May 19, 2026

PDS (PDSB) Q1 2026 Beat: Revenue $N/A, EPS Exceeds by SignificantPositive Surprise Momentum - The Legal Advocate

May 19, 2026
pulisher
May 18, 2026

ETFs Investing in PDS Biotechnology Corp. Stocks - TradingView

May 18, 2026
$91.09
price up icon 1.97%
$118.87
price up icon 1.02%
$34.72
price down icon 0.83%
$58.73
price down icon 0.17%
ONC ONC
$325.90
price up icon 0.00%
$278.40
price up icon 2.44%
大文字化:     |  ボリューム (24 時間):